We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tricida Hit With CRL for Chronic Kidney Disease Drug
Tricida Hit With CRL for Chronic Kidney Disease Drug
The FDA has turned down Tricida’s new drug application for veverimer (TRC101) as a treatment for metabolic acidosis in patients with chronic kidney disease and said it needs to see more supporting data.